Frederic Wafic Karim

Frederic Karim practices at Deaconess Midtown Hospital - Outpatient Therapy in Evansville, Indiana.

Frederic Karim's NPI, 1619553682, was assigned on March 22, 2021. Frederic Karim holds Kentucky license 59611.

Frederic Karim's primary practice is Deaconess Midtown Hospital - Outpatient Therapy, at 600 Mary St, Evansville, IN 47747. The practice phone is (812) 450-3324.

Frederic Karim's primary practice is Deaconess Midtown Hospital - Outpatient Therapy in Evansville, Indiana. Frederic Karim is also affiliated with Deaconess Midtown Hospital. The medical group on file is Deaconess Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Frederic Karim practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Frederic Karim's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Frederic Karim is licensed in Kentucky.

CMS data shows 451 Medicare services from Frederic Karim across 4 procedure codes in 2024, for 154 Medicare patients. Medicare paid $34,729 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 154 Medicare patients who saw Frederic Karim in 2024. The largest group is 65 to 74, with 55 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Frederic Karim's median patient age at 76, with 53% women.

In 2024, Frederic Karim wrote 373 Medicare Part D claims for 120 patients. 82% of them were for generic drugs. CMS names the drug for 84 of them, across 5 drugs with 11 or more claims each, at $515 in total drug cost. In 2023, CMS named 74 claims across 5 drugs.

Frederic Karim accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Frederic Karim from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Shionogi Inc paid the most, $148.